Request availability and a quotation for your required quantity and destination.
| Product | Adapalene 0.1% - Adaferin Gel |
|---|---|
| Categories | Acne Treatment, Skin Care |
| Pack Size | 3 TUBES, 6 Tubes, 1 TUBE |
| Availability | Confirmed on enquiry |
Product listing is not a recommendation to use this medicine. Prescription and destination requirements apply where relevant.
Product categories: Acne Treatment · Skin Care
Improvement may take several weeks, with fuller results often taking 8–12 weeks.
No. Both are topical retinoids, but formulations and tolerability differ.
Dryness, redness and peeling can occur, particularly early in treatment.
Some clinician-approved regimens use both; check for irritation and product compatibility.
Yes. Protect treated skin from excessive UV exposure.
Product information updated: 10 October 2026. Educational information supported by the references below; not an individual prescription.
Adaferin 0.1% Gel is a topical adapalene listing for acne care. Its percentage should not be compared directly with the percentage of tretinoin or another retinoid.
Adapalene helps regulate skin-cell turnover inside follicles, reducing blocked pores and supporting acne control. It can address blackheads, whiteheads and inflammatory spots as part of a suitable regimen. It is not a steroid or an antibiotic.
| Active ingredient | Adapalene |
|---|---|
| Listed formulation | Adapalene 0.1% gel |
| Treatment context | Topical retinoid treatment for acne |
Adapalene 0.1% and tretinoin 0.025% are different molecules; adapalene is not simply four times stronger because its percentage is larger. Formulation and individual response matter when deciding between them.
The most appropriate retinoid depends on sensitivity, formulation, previous response and the rest of your treatment. Painful nodules, scarring or substantial distress are reasons for a clinical review rather than repeatedly trying stronger topical products.
Follow the Adaferin leaflet and your clinician’s instructions. A thin layer is generally directed across the affected acne-prone area rather than piled onto individual spots. Gently cleanse and dry first, keep away from eyes and lips, and do not apply more often to accelerate results.
Redness, dryness, itching, peeling and burning can occur, especially early in treatment. Severe or persistent irritation needs a review; visible peeling is not required for a medicine to be useful.
Stop using the product and seek prompt advice for severe pain, blistering or significant swelling. Breathing difficulty or throat swelling needs emergency help.
Acne response is gradual; some adapalene gel labels allow up to three months to assess visible improvement. Early worsening can occur, but persistent or severe deterioration should not automatically be called purging.
There is no simple potency conversion between these medicines. A clinician should compare clinical suitability rather than percentages alone.
Combining two topical retinoids is not a routine acne strategy and can increase irritation. Do not do so without explicit clinical instructions.
A non-comedogenic moisturiser can support comfort. Ask about timing if your skin is sensitive.
Follow the leaflet: retinoids are commonly used across the affected acne-prone area to address developing blocked pores.
Avoid topical adapalene during pregnancy and pregnancy planning. Ask your clinician about alternatives.
Use these links to understand treatment differences, not to switch or combine medicines without professional advice.
Browse the skincare catalogue for other medicine information.
To enquire about Adaferin 0.1% Gel, provide the strength, requested quantity and destination. Cureiva Healthcare will need to confirm the actual manufacturer, pack, stock and applicable prescription and import requirements before supply. This listing does not establish approval in your country or suitability for you.
Enquire about this product · How to enquire and order
References explain the active ingredient and treatment context. A label for another brand does not establish identical excipients, authorised indications or regulatory approval for this product. Follow the supplied leaflet and your clinician’s instructions.